Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ACCS100 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Aflatoxin Poisoning 1

Interventions

Cyclophosphamide 2793 Cisplatin 2785 Carboplatin 2586 Radiotherapy 2483 Paclitaxel 2372 Gemcitabine 2224 pembrolizumab 2075 Docetaxel 1946 Bevacizumab 1919 Fluorouracil 1632 Capecitabine 1614 Oxaliplatin 1521 Dexamethasone 1391 Nivolumab 1369 Doxorubicin 1313 Rituximab 1307 Magnetic Resonance Spectroscopy 1205 Etoposide 1182 Irinotecan 1096 Leucovorin 1079 Drug Therapy 1047 Cytarabine 1000 fludarabine 928 Pemetrexed 924 Specimen Handling 866 Vincristine 829 Prednisone 828 Lenalidomide 826 Cetuximab 821 Trastuzumab 820

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01677195 2016-04-19

RDMEACCS100

Texas Enterosorbents Incorporated

Phase 2 Completed

234 enrolled 7 charts

Aflatoxin Poisoning, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡